“Thinning hair,” or Androgenetic Alopecia, is one of the most common forms of hair loss. It is characterized by a gradual decrease in hair density, making the scalp more visible. The primary cause is often genetic, leading to hair follicles that are sensitive to male hormones (androgens), particularly Dihydrotestosterone (DHT). This hormone accelerates the hair’s shedding phase and results in the growth of increasingly smaller and finer hairs until the follicles eventually stop producing new hair altogether.

In women, thinning hair typically occurs diffusely across the scalp, especially at the crown or along the hairline, unlike men, who often experience receding hairlines or bald patches. This can make it difficult for women to notice the condition in its early stages, often mistaking it for normal hair shedding.

However, thinning hair is classified as Non-Scarring Alopecia, meaning the hair follicles are not permanently damaged and can be stimulated to recover if diagnosed and treated appropriately from the outset. Allowing thinning hair to worsen without treatment can lead to more severe conditions that require more complex and challenging restoration methods in the future.